By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TissueGene, Inc. 

209 Perry Parkway, Suite 13

Gaithersburg  Maryland  20877  U.S.A.
Phone: 301-921-6000 Fax: 301-921-6011



Company News
TissueGene, Inc. Receives Recommendations From FDA On Pathway To Phase 3 Trial Of TG-C For Treatment Of Osteoarthritis Of The Knee 11/17/2014 10:24:32 AM
TissueGene, Inc. Completes Enrollment in U.S. Phase II Study of TG-C in Patients With Knee Osteoarthritis 11/14/2012 8:33:28 AM
TissueGene, Inc. Initiates Patient Enrollment for a Phase II Study of TG-C for Osteoarthritis of the Knee 5/19/2011 10:02:11 AM
PharmaVigilant Supports TissueGene, Inc.'s Phase II Trial With Groundbreaking Imaging Capabilities 2/2/2010 11:44:05 AM
TissueGene, Inc. Announces Regulatory Allowance to Initiate Phase IIa Study of TG-C in South Korea for Osteoarthritis of the Knee 3/2/2009 10:24:48 AM
TissueGene, Inc. Initiates Phase I Clinical Trial With TG-C 7/24/2006 10:34:34 AM
Tech Council of Maryland Release: Area Life Science Companies Chosen To Make Presentations For Venture Funding At 2005 Mid-Atlantic Bio10/19/2005 5:13:20 PM